Screener
Evolent Health, Inc. EVH Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Evolent Health, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashAndInvestmentsCurrent.
The source filing: Evolent Health, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:53 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628908-26-000086
FAQ
- What is Evolent Health, Inc.'s restricted cash?
- Evolent Health, Inc. (EVH) reported restricted cash of $22.99M in Q2 2026.
- How has Evolent Health, Inc.'s restricted cash changed year-over-year?
- Evolent Health, Inc.'s restricted cash decreased by 5.7% year-over-year, from $24.37M to $22.99M.
- What is the long-term trend for Evolent Health, Inc.'s restricted cash?
- Over 5 years (2020 to 2025), Evolent Health, Inc.'s restricted cash has grown at a 12.7% compound annual growth rate (CAGR), from $14.37M to $26.13M.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.
Ask your AI about Evolent Health, Inc.'s restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude